To Evaluate Safety and Pharmacokinetics of Belinostat in Patients Who Have Mild, Moderate and Severe Renal Impairment.
Clinical trial NCT02679131 · TERMINATED
Trial details
- NCT number
- NCT02679131
- Sponsor
- Acrotech Biopharma Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2017-06-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.